APA

Fiebiger W. C., Scheithauer W., Traub T., Kurtaran A., Gedlicka C., Kornek G. V., Virgolini I. & Raderer M. (20020809). Absence of therapeutic efficacy of the somatostatin analogue lanreotide in advanced primary hepatic cholangiocellular cancer and adenocarcinoma of the gallbladder despite in vivo somatostatin-receptor expression. : Scandinavian journal of gastroenterology.

Chicago

Fiebiger W C, Scheithauer W, Traub T, Kurtaran A, Gedlicka C, Kornek G V, Virgolini I and Raderer M. 20020809. Absence of therapeutic efficacy of the somatostatin analogue lanreotide in advanced primary hepatic cholangiocellular cancer and adenocarcinoma of the gallbladder despite in vivo somatostatin-receptor expression. : Scandinavian journal of gastroenterology.

Harvard

Fiebiger W. C., Scheithauer W., Traub T., Kurtaran A., Gedlicka C., Kornek G. V., Virgolini I. and Raderer M. (20020809). Absence of therapeutic efficacy of the somatostatin analogue lanreotide in advanced primary hepatic cholangiocellular cancer and adenocarcinoma of the gallbladder despite in vivo somatostatin-receptor expression. : Scandinavian journal of gastroenterology.

MLA

Fiebiger W C, Scheithauer W, Traub T, Kurtaran A, Gedlicka C, Kornek G V, Virgolini I and Raderer M. Absence of therapeutic efficacy of the somatostatin analogue lanreotide in advanced primary hepatic cholangiocellular cancer and adenocarcinoma of the gallbladder despite in vivo somatostatin-receptor expression. : Scandinavian journal of gastroenterology. 20020809.